O'Neill Gilmore Neil

Track

Insider profile

Performance

Overall performance
4.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
O'Neill Gilmore Neil's trades of Editas Medicine Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
59.10
Quantity 91,902 -3.0%
Value US$1,341,725
Transaction date
Proposed sale
Price
44.85
Quantity 54,822
Value US$4,469,474
Transaction date
Sale
Price
307.61
Quantity 39,236 -49.5%
Value US$1,194,234
Transaction date
Proposed sale
Price
3.08
Quantity 15,000
Value US$46,200
Transaction date
Proposed sale
Price
1.89
Quantity 6,000
Value US$11,340
Transaction date
Proposed sale
Price
2.50
Quantity 7,000
Value US$17,500
Transaction date
Proposed sale
Price
2.73
Quantity 7,000
Value US$19,110
Transaction date
Proposed sale
Price
1.87
Quantity 20,000
Value US$37,400
Transaction date
Proposed sale
Price
1.86
Quantity 35,000
Value US$65,100
Transaction date
Proposed sale
Price
3.92
Quantity 3,000
Value US$11,760
Transaction date
Proposed sale
Price
5.32
Quantity 24,000
Value US$127,680
Transaction date
Proposed sale
Price
8.86
Quantity 140,000
Value US$1,240,400
Transaction date
Proposed sale
Price
9.18
Quantity 8,500
Value US$78,030
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-03
S Sale
91,902 -3.0%
59.10
US$1,341,725 		91,902 -3.0% 59.10 US$1,341,725
2026-08-31 2026-09-03
PrS Proposed sale
54,822
44.85
US$4,469,474 		54,822 44.85 US$4,469,474
2026-06-05 2026-06-03
S Sale
39,236 -49.5%
307.61
US$1,194,234 		39,236 -49.5% 307.61 US$1,194,234
2026-06-05 2026-06-03
S Sale
15,380 -5.8%
2.70
US$41,543 		15,380 -5.8% 2.70 US$41,543
2026-05-29 2026-06-03
PrS Proposed sale
15,000
3.08
US$46,200 		15,000 3.08 US$46,200
2026-03-04 2026-03-03
S Sale
5,394 -2.0%
2.02
US$10,894 		5,394 -2.0% 2.02 US$10,894
2026-02-27 2026-03-03
PrS Proposed sale
6,000
1.89
US$11,340 		6,000 1.89 US$11,340
2025-12-04 2025-12-03
S Sale
5,603 -2.0%
2.15
US$12,064 		5,603 -2.0% 2.15 US$12,064
2025-12-01 2025-12-03
PrS Proposed sale
7,000
2.50
US$17,500 		7,000 2.50 US$17,500
2025-09-04 2025-09-03
S Sale
5,592 -2.0%
2.60
US$14,517 		5,592 -2.0% 2.60 US$14,517
2025-08-29 2025-09-03
PrS Proposed sale
7,000
2.73
US$19,110 		7,000 2.73 US$19,110
2025-06-04 2025-06-03
S Sale
15,192 -5.1%
1.72
US$26,196 		15,192 -5.1% 1.72 US$26,196
2025-06-02 2025-06-03
PrS Proposed sale
20,000
1.87
US$37,400 		20,000 1.87 US$37,400
2025-03-05 2025-03-04
S Sale
16,632 -5.3%
1.71
US$28,452 		16,632 -5.3% 1.71 US$28,452
2025-02-28 2025-03-03
PrS Proposed sale
35,000
1.86
US$65,100 		35,000 1.86 US$65,100
2024-12-05 2024-12-03
S Sale
1,618 -0.5%
2.08
US$3,361 		1,618 -0.5% 2.08 US$3,361
2024-09-06 2024-09-04
S Sale
1,555 -0.5%
3.42
US$5,325 		1,555 -0.5% 3.42 US$5,325
2024-08-29 2024-09-03
PrS Proposed sale
3,000
3.92
US$11,760 		3,000 3.92 US$11,760
2024-06-06 2024-06-04
S Sale
12,191 -3.7%
5.50
US$66,997 		12,191 -3.7% 5.50 US$66,997
2024-05-31 2024-06-03
PrS Proposed sale
24,000
5.32
US$127,680 		24,000 5.32 US$127,680
2024-03-05 2024-03-05
S Sale
77,824 -19.2%
9.42
US$732,884 		77,824 -19.2% 9.42 US$732,884
2024-03-04 2024-03-04
PrS Proposed sale
140,000
8.86
US$1,240,400 		140,000 8.86 US$1,240,400
2023-06-07 2023-06-05
S Sale
6,486 -4.7%
9.50
US$61,638 		6,486 -4.7% 9.50 US$61,638
2023-06-02 2023-06-05
PrS Proposed sale
8,500
9.18
US$78,030 		8,500 9.18 US$78,030